Norris James P, Shabason Jacob, Halpern Jennifer L, Schwartz Herbert S, Weber Kristy L, Holt Ginger E, Wilson Robert J
Vanderbilt University Medical Center, Nashville, TN, USA.
Spartanburg Regional Healthcare System, Spartanburg, SC, USA.
Ann Jt. 2022 Jul 15;7:24. doi: 10.21037/aoj-20-101. eCollection 2022.
The humerus is a common site of metastatic disease that can be fixated with either plate and screw or intramedullary nail (IMN) constructs. A multicenter retrospective comparison study was undertaken to compare implant survival, complication rate and cost between the two constructs. No prior studies have included a cost comparison.
Databases of two academic practices were queried retrospectively to identify patients with metastases of the humerus. Inclusion criteria were a lesion in the proximal metaphysis to distal diaphysis and amenable to both implant options with available cost data. Follow-up was at least 6 months barring death or discharge to hospice sooner. Demographic, clinical and outcome data was recorded. Costs were estimated based on contract pricing. Operating room (OR) costs were estimated using per minute OR costs proposed by other investigators.
One hundred and one humeri in 96 patients were included (72 plates and 29 nails). The most common malignancies were renal cell, myeloma and lung. Half presented with a displaced fracture. Demographics were similar in both groups. Lesions were larger in the plate group. Surgical times were longer in the plate group, 146 75 min, P<0.001. Estimated blood loss (EBL) was higher in the plate group, 510 221 mL, P<0.001. A trend toward increased failure was seen in the plate group, 12.5% 0% (P=0.056). The most common complications in the plate group were pain, stiffness and swelling compared to pain, refracture and PE in the nail group. Local disease progression was equivalent. Implant costs were higher in the IMN group ($2,753 $1,553, P<0.001), while OR costs were lower ($2,349 $4,395, P<0.001). Overall cost of implantation was lower in the IMN group ($5,102 $5,949, P=0.005).
IMN of metastases of the humerus offers a faster, potentially more durable construct with lower blood loss, faster OR times and decreased cost of implantation.
肱骨是转移性疾病的常见部位,可采用钢板螺钉或髓内钉(IMN)固定结构进行固定。进行了一项多中心回顾性比较研究,以比较两种固定结构的植入物存活率、并发症发生率和成本。此前尚无研究进行成本比较。
对两家学术机构的数据库进行回顾性查询,以确定肱骨转移患者。纳入标准为近端干骺端至远端骨干有病变,且两种植入物选择均适用且有可用成本数据。除非死亡或提前出院至临终关怀机构,否则随访至少6个月。记录人口统计学、临床和结果数据。成本根据合同定价估算。手术室(OR)成本使用其他研究者提出的每分钟OR成本进行估算。
纳入96例患者的101根肱骨(72例使用钢板,29例使用髓内钉)。最常见的恶性肿瘤为肾细胞癌、骨髓瘤和肺癌。半数患者表现为移位骨折。两组的人口统计学特征相似。钢板组的病变更大。钢板组的手术时间更长,为146±75分钟,P<0.001。钢板组的估计失血量(EBL)更高,为510±221毫升,P<0.001。钢板组有失败增加的趋势,为12.5%±0%(P=0.056)。钢板组最常见的并发症为疼痛、僵硬和肿胀,而髓内钉组为疼痛、再骨折和肺栓塞。局部疾病进展情况相当。髓内钉组的植入物成本更高(2753美元±1553美元,P<0.001),而手术室成本更低(2349美元±4395美元,P<0.001)。髓内钉组的总体植入成本更低(5102美元±5949美元,P=0.005)。
肱骨转移瘤的髓内钉固定提供了一种更快、可能更持久的固定结构,失血量更少,手术室时间更快,植入成本降低。